Optimizing HIV-1 Treatment with Pharmacogenomic (PGx) Testing HIV-1 (Human Immunodeficiency Virus type 1) positions a worldwide health concern and requires tailored treatment approaches. Over time, there have been notable innovations in addressing HIV-1, resulting in better overall well-being and extended lifespan for affected individuals. While antiretroviral therapy (ART) remains central to HIV-1 treatment, determining the […]